ClinicalTrials.govpublic full text
Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
coronary heart disease, apolipoprotein a-i,, atherosclerosis,, hdl,, inflammation,, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830135
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.